Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction

SUFU Events

SUFU 2020 Winter Meeting
February 25 - 29, 2020
JW Marriott Scottsdale Camelback Inn
Scottsdale, AZ

Registration Now Open

SUFU 2020 Annual Meeting At the AUA
May 15, 2020
Renaissance Washington DC Hotel
Washington, DC

AUA 2020
May 15 - 18, 2020
Walter E. Washington Convention Center
Washington, DC

Registration Now Open

SUFU Research Foundation Resident Preceptorship 2020
July 31 - August 2, 2020
The Westin O'Hare
Rosemont, IL

SUFU 2021 Winter Meeting
February 22 - 28, 2021
Grand Hyatt Nashville
Nashville, TN

SUFU 2022 Winter Meeting
February 22 - 26, 2022
Marriott Marquis San Diego Marina
San Diego, CA

See All Events

Another successful SUFU Foundation Preceptorship Program on the Books!
Thank you to the faculty and residents that made it a great weekend! read more »

view video

SUFU Statement Regarding FDA Communication on “Vaginal Rejuvenation”
read more »

Announcing the SUFU Visiting Professorship
This 1-day visiting professorship will be offered to interested training programs and will consist of a lecture series from a member of the SUFU Executive Committee encompassing all aspects of FPMRS, Urodynamics, and Neurourology. read more »

Overactive Bladder Clinical (OAB) Care Pathway
SUFU is providing the Overactive Bladder Clinical Care Pathway for use by providers and patients. Overactive Bladder CCP Provider Flowchart »Overactive Bladder CCP Patient Roadmap » read more »

Fellowships

Accredited | Non-Accredited
Updates & Announcements

Guidelines

AUA/SUFU Guidelines

SUFU MUS
Updates

NAU Online Journal

Donate

Donate to the
SUFU Research Foundation

News & Announcements

Fellowship Opportunity at Houston Methodist Houston Methodist has a Urology fellowship position opening this summer, 2020 for their newly accredited Female Pelvic Medicine and Reconstructive Surgery Urology Fellowship Program at Houston Methodist Hospital.... [read more]
Update: Important Message About FDA Statement on MUS On April 16, 2019, the U.S. Food and Drug Administration (FDA) issued an unexpected mandate recalling and halting the distribution of all remaining surgical mesh indicated for transvaginal (TV) repair of pelvic organ prolapse (POP), effective immediately.... [read more]

View All Prev Next

Neurourology and Urodynamics

Method of limits: Female genital stretch perception thresholds

Saturday, February 1, 2020

Readability of pelvic floor dysfunction questionnaires